Evidence map›Paper›PMID 41870130›Full record

ArticleBriefings in bioinformatics2026

Enhancing cancer classification accuracy with a self-attention network using panel capture sequencing data.

Yi Jia, Chan Zhang, Han Zhang, Kang Dong, Yuruo Hu, Yinan Wang, Zicheng Zhao

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yi JiaKey Laboratory for Early Diagnosis and Biotherapy of Malignant Tumors in Children and Women, Dalian Women and Children's Medical Group, 154 Zhong Shan Road, Xigang, Dalian 116012, China.ORCID 0009-0004-2702-7956
Chan ZhangKey Laboratory for Early Diagnosis and Biotherapy of Malignant Tumors in Children and Women, Dalian Women and Children's Medical Group, 154 Zhong Shan Road, Xigang, Dalian 116012, China.
Han ZhangDepartment of Forensic Medicine, Guizhou Medical University, No. 9, Beijing Road, Yunyan District, Guiyang 550025, China.
Kang DongShenzhen Byoryn Technology Co., Ltd, No. 32, Shihua Road, Futian District, Shenzhen 518000, China.
Yuruo HuShenzhen Byoryn Technology Co., Ltd, No. 32, Shihua Road, Futian District, Shenzhen 518000, China.
Yinan WangOmicLab Ltd., Unit 917, 9/F, Building 19W, No. 19 Science Park West Avenue, Hong Kong Science Park, Pak Shek Kok, N.T., HongKong, China.
Zicheng ZhaoShenzhen Byoryn Technology Co., Ltd, No. 32, Shihua Road, Futian District, Shenzhen 518000, China.

Funding

Dalian Science and Technology BureauGuidance Program of Life and Health Field of Dalian City 2024ZDJH01PT039
6 · The paper itself

Abstract

Cancer classification is pivotal for precision oncology, yet traditional methods struggle with the molecular heterogeneity of tumors. Our study introduces a self-attention based Conv1D machine learning network designed for panel capture sequencing data, which is more commonly used in clinical settings. Combining clinical capture sequencing data and The Cancer Genome Atlas data, we achieved an overall classification accuracy of over 90%, with precision rates reaching 100% for cervical and gastric cancers. Additionally, recall rates were highest at 95.79% for gastric cancer and lowest at 77.46% for cervical cancer, demonstrating robust performance across various cancer types. The model identified key genes such as C3orf36, JHY, and TASP1, showing significant differences in mutation counts across cancers. High-impact gene enrichment analysis highlighted critical pathways like acute myeloid leukemia and adipocytokine signaling. This approach not only significantly improves the precision of cancer classification, demonstrating the potential for clinical application, but also enhances our understanding of cancer biology.

Indexed as

High-Throughput Nucleotide SequencingMachine LearningNeoplasmsClassification AlgorithmsFemaleHumansMutationcancer classificationself-attention Conv1D networksingle nucleotide mutation

Identifiers

PMID41870130
PMCPMC13006975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.